Explore

Trendline Trendline
Zura Bio Appoints Muzammil Mustufa as Chief Business Officer to Drive Strategic Growth

Zura Bio Appoints Muzammil Mustufa as Chief Business Officer to Drive Strategic Growth

Zura Bio Appoints Muzammil Mustufa as Chief Business Officer to Drive Strategic Growth
Trendline Trendline
Palatin Technologies Reports Q3 2026 Financial Results and Business Update

Palatin Technologies Reports Q3 2026 Financial Results and Business Update

Palatin Technologies Reports Q3 2026 Financial Results and Business Update
Trendline Trendline
Palatin Technologies Reports Q3 2026 Financial Results and Business Progress

Palatin Technologies Reports Q3 2026 Financial Results and Business Progress

Palatin Technologies Reports Q3 2026 Financial Results and Business Progress
Trendline Trendline
Palatin Reports Reduced Net Loss and Advances Obesity Programs

Palatin Reports Reduced Net Loss and Advances Obesity Programs

Palatin Reports Reduced Net Loss and Advances Obesity Programs
Trendline Trendline
Galapagos Rebrands as Lakefront Biotherapeutics Amid Strategic Shift

Galapagos Rebrands as Lakefront Biotherapeutics Amid Strategic Shift

Galapagos Rebrands as Lakefront Biotherapeutics Amid Strategic Shift
Trendline Trendline
Anaveon Appoints Thomas P. Mathers as Chair of the Board of Directors, Signaling Strategic Growth

Anaveon Appoints Thomas P. Mathers as Chair of the Board of Directors, Signaling Strategic Growth

Anaveon Appoints Thomas P. Mathers as Chair of the Board of Directors, Signaling Strategic Growth
Trendline Trendline
Immunome Submits NDA for Varegacestat and Reports Financial Results

Immunome Submits NDA for Varegacestat and Reports Financial Results

Immunome Submits NDA for Varegacestat and Reports Financial Results
Trendline Trendline
Perspective Therapeutics Advances VMT-α-NET with High Efficacy in Clinical Trials

Perspective Therapeutics Advances VMT-α-NET with High Efficacy in Clinical Trials

Perspective Therapeutics Advances VMT-α-NET with High Efficacy in Clinical Trials
Trendline Trendline
Anaveon Appoints Thomas P. Mathers as Chair of the Board of Directors

Anaveon Appoints Thomas P. Mathers as Chair of the Board of Directors

Anaveon Appoints Thomas P. Mathers as Chair of the Board of Directors
Trendline Trendline
Symeres Appoints Henning Steinhagen as CEO to Drive Growth

Symeres Appoints Henning Steinhagen as CEO to Drive Growth

Symeres Appoints Henning Steinhagen as CEO to Drive Growth
Trendline Trendline
AI and Biotechnology Convergence Drives Personalized Medicine Advancements

AI and Biotechnology Convergence Drives Personalized Medicine Advancements

AI and Biotechnology Convergence Drives Personalized Medicine Advancements
Trendline Trendline
AN2 Therapeutics Advances Multiple Drug Programs with New Phase 2 Trials

AN2 Therapeutics Advances Multiple Drug Programs with New Phase 2 Trials

AN2 Therapeutics Advances Multiple Drug Programs with New Phase 2 Trials